Ignite Creation Date:
2025-12-25 @ 12:56 AM
Ignite Modification Date:
2025-12-26 @ 6:18 PM
Study NCT ID:
NCT00834067
Status:
COMPLETED
Last Update Posted:
2024-08-20
First Post:
2009-01-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Moexipril HCl/Hydrochlorothiazide 15/25 mg Tablets Under Non-Fasting Conditions
Sponsor:
Teva Pharmaceuticals USA
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-10
Start Date Type:
None
Primary Completion Date:
2003-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2003-11
Completion Date Type:
ACTUAL
First Submit Date:
2009-01-30
First Submit QC Date:
None
Study First Post Date:
2009-02-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-07-02
Results First Submit QC Date:
None
Results First Post Date:
2009-08-18
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-16
Last Update Post Date:
2024-08-20
Last Update Post Date Type:
ACTUAL